Pallas Capital Advisors LLC Biogen Inc. Transaction History

Pallas Capital Advisors LLC

$2.24 Billion
Q1 2025

A detailed history of Pallas Capital Advisors LLC transactions in Biogen Inc. stock. As of the latest transaction made, Pallas Capital Advisors LLC holds 13,345 shares of BIIB stock, worth $1.58 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

13,345

Previous 5,651 136.15%

Holding current value

$1.58 Million

Previous $864,000 111.34%

% of portfolio

0.08%

Previous 0.04%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 14, 2025	BUY	$133.43 - $153.27 $1.03 Million - $1.18 Million	7,694 Added 136.15%	13,345 $1.83 Million
Q4 2024 Jan 13, 2025	BUY	$146.47 - $191.55 $453,324 - $592,847	3,095 Added 121.09%	5,651 $864,000
Q3 2024 Oct 25, 2024	SELL	$189.07 - $236.8 $8,508 - $10,656	-45 Reduced 1.73%	2,556 $495,000
Q2 2024 Jul 19, 2024	SELL	$190.52 - $236.72 $11,050 - $13,729	-58 Reduced 2.18%	2,601 $602,000
Q1 2024 Apr 15, 2024	BUY	$212.02 - $267.71 $563,761 - $711,840	2,659 New	2,659 $573,000
Q3 2023 Nov 01, 2023	SELL	$253.3 - $285.89 $46,353 - $52,317	-183 Reduced 6.4%	2,677 $688,000
Q2 2023 Jul 26, 2023	SELL	$275.25 - $318.06 $52,848 - $61,067	-192 Reduced 6.29%	2,860 $814,000
Q1 2023 May 02, 2023	SELL	$256.56 - $292.34 $1,539 - $1,754	-6 Reduced 0.2%	3,052 $848,000
Q4 2022 Jan 24, 2023	BUY	$252.44 - $306.72 $1,009 - $1,226	4 Added 0.13%	3,058 $0
Q3 2022 Nov 07, 2022	SELL	$194.69 - $268.46 $29,398 - $40,537	-151 Reduced 4.71%	3,054 $856,000
Q2 2022 Aug 11, 2022	SELL	$187.54 - $223.02 $14,065 - $16,726	-75 Reduced 2.29%	3,205 $661,000
Q1 2022 Apr 20, 2022	SELL	$193.77 - $244.14 $43,210 - $54,443	-223 Reduced 6.37%	3,280 $697,000
Q4 2021 Feb 01, 2022	BUY	$223.92 - $287.77 $30,453 - $39,136	136 Added 4.04%	3,503 $772,000
Q3 2021 Nov 12, 2021	BUY	$282.99 - $369.05 $18,960 - $24,726	67 Added 2.03%	3,367 $941,000
Q2 2021 Aug 11, 2021	SELL	$259.0 - $414.71 $20,461 - $32,762	-79 Reduced 2.34%	3,300 $1.12 Million
Q1 2021 May 14, 2021	BUY	$242.95 - $284.63 $820,928 - $961,764	3,379 New	3,379 $931,000

Others Institutions Holding BIIB

# of Institutions

1,016

Shares Held

127M

Call Options Held

1.77M

Put Options Held

2.34M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $17.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pallas Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pallas Capital Advisors LLC with notifications on news.

Account

Pallas Capital Advisors LLC Biogen Inc. Transaction History